Effects of 12-Week Supplementation with Coffee Diterpene Cafestol
Study Overview
This study looked at how cafestol, a compound found in coffee, affects healthy individuals with a larger waist size who are at risk of type 2 diabetes. Previous research shows coffee may help lower diabetes risk, but the effects of cafestol in humans needed more exploration.
Study Details
In this 12-week trial, 40 participants were randomly assigned to receive either cafestol (6 mg twice daily) or a placebo. Various tests, including insulin suppression tests and MRI scans, were conducted before and after the treatment period.
Key Findings
- No change in insulin sensitivity or glucose tolerance: Cafestol did not improve these metabolic parameters.
- Weight and fat reduction: Participants taking cafestol lost 2% of body weight, 5% of visceral fat volume, and saw a 15% decrease in gamma-glutamyl transferase levels compared to the placebo group.
Conclusions
Cafestol may help with weight and visceral fat reduction, but it did not improve insulin sensitivity or glucose tolerance in this study. It could still play a role in the link between coffee consumption and lower diabetes risk. Future studies should test higher doses and longer treatment times, especially for those with glucose metabolism issues.
Clinical Trial Importance
Clinical trials are essential for developing safe and effective treatments. Our AI-driven platform, DocSym, helps clinicians access consolidated standards and research, making it easier to implement findings in everyday practice.
Enhancing Healthcare Operations
In today’s healthcare landscape, efficiency is vital. Our mobile apps facilitate scheduling, treatment monitoring, and telemedicine, improving patient care management and expanding digital services.
Improving Patient Outcomes
By leveraging AI, clinics can streamline workflows, enhance patient outcomes, and reduce reliance on paper processes. Discover how we can assist you at aidevmd.com.